期刊文献+

慢性肾脏病患者血尿酸水平变化及影响因素 被引量:4

下载PDF
导出
摘要 目的探讨慢性肾脏病(CKD)患者血清尿酸水平变化及影响因素。方法回顾性分析明确诊断为CKD患者418例,依据肾脏功能分期分为5组。检测血清肌酐、血尿素氮、血尿酸及血脂水平,分析影响血尿酸水平的因素。结果 CKD患者肾小球滤过率GFR<60 mL/(min·1.73 m^2)组(3期、4期、5期)的血尿酸水平较GFR≥60 mL/(min·1.73 m^2)组(1期、2期)明显升高,差异有统计学意义(P<0.05);CKD血尿酸水平与GFR呈负相关性(r-0.355,P<0.05)。CKD的GFR <60 mL/(min·1.73 m^2)患者中高尿酸血症组与尿酸正常组相比,性别、合并糖尿病差异有统计学意义(P<0.05);高尿酸血症组较尿酸正常组甘油三酯水平升高,差异无统计学意义(P>0.05)。多因素Logistic回归分析显示,CKD的GFR<60 mL/(min·1.73 m^2)患者HUA的独立危险因素为性别、合并糖尿病、甘油三脂(P<0.05)。结论 CKD的GFR<60 mL/(min·1.73 m^2)患者血尿酸水平明显升高,与肾功能损害程度存在直线相关关系,性别、合并糖尿病、甘油三酯均是其发生的独立危险因素。
出处 《宁夏医学杂志》 CAS 2019年第4期335-337,共3页 Ningxia Medical Journal
基金 宁夏重点研发计划重大重点项目(东西部合作:2018BFG02010) 宁夏重点研发计划一般项目(2018BEG03053) 西北民族大学中央高校基本科研资金项目(31920160104) 宁夏自然科学基金项目(NZ16183)
  • 相关文献

参考文献3

二级参考文献22

  • 1JOHNSON R J, KANG D H, FEIG D, et al. Is there a pathogenetie role for uric acid in hypertension and cardiovascular and renal disease? [J]. Hypertension, 2003, 41(6): 1183-1190.
  • 2HOVIND P, ROSSING P, JOHNSON R J, et al. Serum uric acid as a new player in the development of diabetic nephropathy[J]. J Ren Nutr, 2011, 21(1): 124-127.
  • 3NELSON R G, TUTTLE K R. The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes andCKD[J]. Blood Purif, 2007, 25(1): 112-114.
  • 4HOEFIELD R A, KALRA P A, BAKER P G, et al. The use of eGFR and ACR to predict decline in renal function in people with diabetes[J]. Nephrol Dial Transplant, 2011, 26(3):887- 892.
  • 5BONAKDARAN S, HAMI M, SHAKERI M T. Hyperuricemia and albuminuria in patients with type 2 diabetesmellitus[J]. IranJKidneyDis, 2011, 5(1): 21-24.
  • 6MAXWELL A l, BRUINSMA K A. Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease [J]. J Am Coll Cardiol, 2001, 38(7) : 1850 -1858.
  • 7KANELLIS J, WATANABE S, LI J H, et al. Uric acid stimulates monocyte chemoattractant protein I production in vascular smooth muscle cells via initogen-activated protein kinase and cyclooxygenase-2[J]. Hypertension, 2003, 41 (6) : 1287- 1293.
  • 8SEET R C, KASIMAN K, GRUBER J, et al. Prospective cohort study[J]. Atherosclerosis, 2010, 209(1): 215-219.
  • 9Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Current opinion in rheumatology, 2013, 25(2):210- 216.
  • 10Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. The New England journal of medicine, 2013, 369(2):145.

共引文献21

同被引文献45

引证文献4

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部